Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Mapping HPV Vaccination and Cervical Cancer Screening Practice in the Pacific Region-Strengthening National and Regional Cervical Cancer Prevention

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A systematic review of cervical cancer incidence and mortality in the Pacific Region

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Incidence of HPV-related Anogenital Intraepithelial Neoplasia and Cancer in Men With Diabetes Compared With the General Population

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antidepressant prescriptions and associated factors in men with prostate cancer and their female partners

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of Anogenital Warts in Renal Transplant Recipients Compared with Immunocompetent Controls: A Cross-sectional Clinical Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • J Obel
  • J McKenzie
  • L E Buenconsejo-Lum
  • Anne Mette Durand
  • A Ekeroma
  • Y Souares
  • D Hoy
  • W Baravilala
  • S M Garland
  • S K Kjaer
  • A Roth
View graph of relations

OBJECTIVE: To provide background information for strengthening cervical cancer prevention in the Pacific by mapping current human papillomavirus (HPV) vaccination and cervical cancer screening practices, as well as intent and barriers to the introduction and maintenance of national HPV vaccination programmes in the region.

MATERIALS AND METHODS: A cross-sectional questionnaire-based survey among ministry of health officials from 21 Pacific Island countries and territories (n=21).

RESULTS: Cervical cancer prevention was rated as highly important, but implementation of prevention programs were insufficient, with only two of 21 countries and territories having achieved coverage of cervical cancer screening above 40%. Ten of 21 countries and territories had included HPV vaccination in their immunization schedule, but only two countries reported coverage of HPV vaccination above 60% among the targeted population. Key barriers to the introduction and continuation of HPV vaccination were reported to be: (i) Lack of sustainable financing for HPV vaccine programs; (ii) Lack of visible government endorsement; (iii) Critical public perception of the value and safety of the HPV vaccine; and (iv) Lack of clear guidelines and policies for HPV vaccination.

CONCLUSION: Current practices to prevent cervical cancer in the Pacific Region do not match the high burden of disease from cervical cancer. A regional approach, including reducing vaccine prices by bulk purchase of vaccine, technical support for implementation of prevention programs, operational research and advocacy could strengthen political momentum for cervical cancer prevention and avoid risking the lives of many women in the Pacific.

Original languageEnglish
JournalAsian Pacific Journal of Cancer Prevention
Volume16
Issue number8
Pages (from-to)3435-42
Number of pages8
ISSN1513-7368
Publication statusPublished - 2015

ID: 45848213